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Human 
Rickettsia sibirica 
mongolitimonae 
Infection, Spain
To the Editor: Rickettsia sibirica 
mongolitimonae has been recently re-
ported as a subspecies of R. sibirica 
(1). The ﬁ  rst evidence of R. sibirica 
mongolitimonae pathogenicity in hu-
mans was documented in France in 
1996 (2). Since then, 11 more cases in 
France, Algeria, South Africa, Greece, 
and Portugal have been reported (3–
6). Because the main clinical mani-
festations include lymphangitis, the 
acronym LAR (lymphangitis-associ-
ated rickettsiosis) has been proposed 
(3). We report a case from Spain that 
conﬁ  rms the broad distribution of this 
agent in southern Europe.
A 41-year-old man was admitted 
on June 19, 2007, to the Hospital de 
Cruces (Baracaldo, Spain) with fever 
(39°C), malaise for a week, sweating, 
lumbar and knee pain, disseminated 
myalgias, and headache. He reported 
that 20 days before admission he had 
removed an engorged tick from his 
right leg while working as a topogra-
pher in the Balmaseda Mountains, 30 
km from Bilbao. He had also removed 
several ticks from his body 4 days be-
fore the onset of symptoms. Physical 
examination did not demonstrate rel-
evant ﬁ  ndings. There was no inocula-
tion eschar at the tick-bite sites. Rash, 
lymphadenopathies, and lymphangitis 
were not observed.
Chest radiograph did not show 
consolidation or other abnormal-
ity. Initial laboratory examination, 
on June 21, 2007, showed a leuko-
cyte count 5.2 × 103/μL, hemoglobin 
14.1 g/dL, platelet count 190,000/μL, 
erythrocyte sedimentation speed 9 
mm/h, urea 38 mg/dL, creatinine 0.9 
mg/dL, aspartate aminotransferase 
229 IU/L, alanine aminotransferase 
170 IU/L, alkaline phosphatase 158 
IU/L, gamma-glutamyl-transpeptidase 
111 IU/L, total bilirubin 1.3 mg/dL, 
and C-reactive protein 4.3 mg/dL. Be-
cause the patient had been bitten by a 
tick, acute-phase serum and EDTA-
treated blood samples were sent to the 
Special Pathogens Laboratory (Área 
de Enfermedades Infecciosas – Hospi-
tal San Pedro from La Rioja), where a 
presumptive diagnosis of rickettsiosis 
was made. On June 22, 2007, treat-
ment with doxycycline was begun 
(100 mg/day for 12 days), and his con-
dition rapidly improved.
The early-phase serum yielded 
low immunoglobulin (Ig) G titer 
(<64) against Rickettsia conorii and 
Anaplasma phagocytophilum anti-
gens, and results of ELISA and West-
ern blotting for Lyme borreliosis were 
negative. A convalescent-phase serum 
sample collected 7 weeks later did not 
contain IgG antibodies against spotted 
fever group Rickettsia species when R. 
conorii antigen was used.
DNA was extracted from the 
early whole-blood specimen by using 
QIAamp DNA Blood minikit (QIA-
GEN, Hilden, Germany) according to 
the manufacturer’s instructions. This 
DNA extract was used as template 
in nested PCR assays targeting the 
spotted fever group rickettsial ompB 
(420 bp) and gltA (337 bp) genes (7). 
Quality control included both positive 
(with R. conorii Malish #7 grown in 
Vero cells) and negative controls that 
were extracted and PCR ampliﬁ  ed in 
parallel with the specimens. Negative 
controls consisted of sterile water in-
stead of template DNA. Ampliﬁ  cation 
products of the expected size were 
obtained. The sequences of these am-
plicons allowed the identiﬁ  cation of R. 
sibirica mongolitimonae with 99.5% 
and 100% similarity for ompB and 
gltA, respectively (GenBank accession 
nos. DQ097083 and DQ097081).
To our knowledge, Rickettsia spe-
cies have never been detected in ticks 
or human specimens in Spain. The host 
ticks of this rickettsia are likely Hya-
lomma species, which are more preva-
lent in southern Spain. In our region 
in northern Spain, Hyalomma mar-
ginatum represented 8% of ticks that 
fed on humans during 2001–2005, al-
though an increase in this number was 
recorded last year (data not shown).
In our patient, Rickettsia’s patho-
genic role was demonstrated by PCR, a 
technique that has previously enabled 
us to identify other arthropod-borne 
Rickettsia species (8,9). This case 
suggests that R. sibirica mongoliti-
monae infection should be considered 
in the differential diagnosis of rick-
ettsiosis and tick-bite febrile patients 
in Spain and conﬁ  rms the distribution 
of this rickettsia in southern Europe. 
According to the literature (3), some 
patients in whom R. sibirica mongoli-
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timonae infection is diagnosed have 
>1 eschar, which raises the suspicion 
that some cases of Mediterranean 
spotted fever with multiple eschars 
reported in Spain could be caused by 
this rickettsial species. More studies 
about the vectors of this bacteria are 
needed because studies of Hyalomma 
and Rhipicephalus ticks (the suspect-
ed hosts) conducted in our area have 
not demonstrated the presence of this 
Rickettsia species.
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Lymphangitis in a 
Portuguese Patient 
Infected with 
Rickettsia sibirica
To the Editor: We report a case 
of Rickettsia sibirica mongolitimoni-
ae strain infection associated with 
lymphangitis (1). A 44-year-old man 
was admitted to São Bernardo Hos-
pital in Setubal, Portugal, on August 
21, 2006. Twelve days previously 
while on vacation at Troia Peninsula, 
he noted malaise, insomnia, and dry 
buccal mucosa. The next day he ob-
served a small erythematous pruritic 
lesion on the lower right forearm that 
2 days later developed into an eschar. 
He also had fever and sought medical 
care. After treatment with topical baci-
tracin, ﬂ  oxacillin, and acetaminophen 
for 2 days, fever (38.7°C) continued 
with lymphangitis extending from the 
right wrist to the elbow. The medica-
tion was changed to nimesulide. Three 
days later a rash developed on the trunk 
and arms, and lymphangitis extended 
to the axilla. Fever and chills contin-
ued, leading to hospital admission. 
No history of tick exposure was re-
ported. Physical examination showed 
blood pressure 128/73 mm Hg, pulse 
96/min, and a rubbery, nontender right 
supraclavicular lymph node ≈1 cm in 
diameter. Several 5- to 10-mm macu-
lopapular erythematous lesions were 
observed on the patient’s palms. He 
had inﬂ   ammation on the right fore-
arm suggestive of lymphangitis and 
an eschar with surrounding edema 
and erythema on the dorsal lower 
right forearm (Figure). Admission 
evaluation showed platelets 117,000/
μL, total bilirubin 0.42 mg/dL, albu-
min 3.42 g/dL, creatinine 1.1 mg/dL, 
alanine aminotransferase 244 U/L, 
aspartate aminotransferase 54 U/L, 
alkaline phosphatase 1061 U/L, cre-
atine phosphokinase 87 U/dL, lactate 
dehydrogenase 784 U/L, C-reactive 
protein 7.1 mg/dL, radiographic pul-
monary diffuse reticular pattern, arte-
rial pO2 68 mm Hg, O2 saturation 94%, 
pCO2 22 mm Hg, and arterial blood 
pH 7.35. The differential diagnoses 
included rickettsiosis, pneumonia, and 
cellulitis. Treatment with vancomycin, 
ceftriaxone, and 100 mg of doxycy-
cline twice a day was begun. On the 
day after hospitalization, a heparinized 
blood sample and 2 skin biopsy sam-
ples were collected. Vancomycin and 
ceftriaxone were discontinued at 48 
hours when rickettsial infection was 
conﬁ  rmed by PCR on skin biopsy; 48 
hours later, the patient was afebrile.
Immunoﬂ   uorescence assay for 
antibodies that used R. sibirica mon-
golitimonae strain as antigen demon-
strated seroconversion with no anti-
bodies in the serum sample collected 
on August 21 and immunoglobulin G 
(IgG) and IgM antibodies at a titer of 
256 in serum collected on August 30. 
DNA was extracted from 1 skin bi-
opsy sample by using a DNeasy Tis-
sue Kit (QIAGEN, Hilden, Germany). 
The products of nested PCR showed 
100% similarity with gltA (353/353) 
and  ompA (350/350) nucleotide se-
quences of R. sibirica mongolitimo-
nae strain (GenBank accession nos. 
DQ423368.1 and DQ423367.1) (1).
Cutaneous biopsy indicated epi-
dermal and dermal necrosis with 
extensive lymphocyte- and macro-
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